Phase I clinical trial designs in oncology: A systematic literature review from 2020 to 2022
Abstract Background: Phase I clinical trials aim to find the highest dose of a novel drug that may be administrated safely without having serious adverse effects. Model-based designs have recently become popular in dose-finding procedures. Our objective is to provide an overview of phase I clinica...
Saved in:
| Main Authors: | Ning Li, Xitong Zhou, Donglin Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2024-01-01
|
| Series: | Journal of Clinical and Translational Science |
| Subjects: | |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124005995/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comprehensive comparison of phase I dose escalation methods
by: Efehan Ulas, et al.
Published: (2018-11-01) -
SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocolsResearch in context
by: Moreno Ursino, et al.
Published: (2025-01-01) -
CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trialsResearch in context
by: Jan Rekowski, et al.
Published: (2025-01-01) -
Investigating dose finding methods and different priors in Bayesian continual reassessment method
by: Tuba Koc, et al.
Published: (2020-01-01) -
Toxicity Estimation of Unspecific Medicinal Antiviral Agents for Prophylaxis and Therapy of Hazard and Especially Hazard Viral Infections
by: S. YA. Loginova, et al.
Published: (2020-05-01)